Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Mallinckrodt
Chinese Patent Office
Argus Health
Teva
Baxter
US Army
Cerilliant
Queensland Health
Johnson and Johnson

Generated: October 19, 2017

DrugPatentWatch Database Preview

LEFLUNOMIDE Drug Profile

« Back to Dashboard

Which patents cover Leflunomide, and what generic Leflunomide alternatives are available?

Leflunomide is a drug marketed by Alembic Pharms Ltd, Barr, Teva Pharms, Sandoz, Heritage Pharms Inc, and Apotex Inc. and is included in seven NDAs.

The generic ingredient in LEFLUNOMIDE is leflunomide. There are six drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the leflunomide profile page.

Summary for Tradename: LEFLUNOMIDE

US Patents:0
Applicants:6
NDAs:7
Suppliers / Packagers: see list9
Bulk Api Vendors: see list85
Clinical Trials: see list53
Patent Applications: see list5,940
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LEFLUNOMIDE at DailyMed

Pharmacology for Tradename: LEFLUNOMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alembic Pharms Ltd
LEFLUNOMIDE
leflunomide
TABLET;ORAL091369-001Nov 21, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
LEFLUNOMIDE
leflunomide
TABLET;ORAL077085-001Sep 13, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Barr
LEFLUNOMIDE
leflunomide
TABLET;ORAL077083-002Sep 13, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
LEFLUNOMIDE
leflunomide
TABLET;ORAL077087-002Sep 13, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
LEFLUNOMIDE
leflunomide
TABLET;ORAL077085-002Sep 13, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
LEFLUNOMIDE
leflunomide
TABLET;ORAL077090-002Sep 13, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Alembic Pharms Ltd
LEFLUNOMIDE
leflunomide
TABLET;ORAL091369-002Nov 21, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Barr
LEFLUNOMIDE
leflunomide
TABLET;ORAL077083-001Sep 13, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
LEFLUNOMIDE
leflunomide
TABLET;ORAL077084-002Sep 13, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
LEFLUNOMIDE
leflunomide
TABLET;ORAL077084-001Sep 13, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Healthtrust
Accenture
Merck
Cantor Fitzgerald
Teva
UBS
AstraZeneca
Federal Trade Commission
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot